Advertisement
Advertisement
URGN
UroGen Pharma Ltd. Ordinary Shares
43.49
USDSponsored
+1.75
+4.19%
Sep 16, 15:59 UTC -4
Closed
After-Market
44.25
+0.76
+1.76%
UroGen Pharma Ltd. Ordinary Shares Financial Snapshot
| Market Cap | 2.16B |
| Beta | 1.57 |
| Earnings Per Share (EPS) | -1.98 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -51.73% |
| Total Debt/Equity (D/E) | -145.84% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 3.80% |
| Free Cash Flow | -78.44M |